- Home
- ASRT vs ADAG Comparison
ASRT vs ADAG Comparison
Compare ASRT & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ADAG
- Stock Information
- Founded
- ASRT 1995
- ADAG 2011
- Country
- ASRT United States
- ADAG China
- Employees
- ASRT N/A
- ADAG N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- ADAG Health Care
- Exchange
- ASRT Nasdaq
- ADAG Nasdaq
- Market Cap
- ASRT 83.2M
- ADAG 84.4M
- IPO Year
- ASRT 1997
- ADAG 2021
- Fundamental
- Price
- ASRT $0.80
- ADAG $1.88
- Analyst Decision
- ASRT Strong Buy
- ADAG Strong Buy
- Analyst Count
- ASRT 1
- ADAG 3
- Target Price
- ASRT $3.00
- ADAG $7.67
- AVG Volume (30 Days)
- ASRT 594.7K
- ADAG 82.3K
- Earning Date
- ASRT 11-10-2025
- ADAG 08-12-2025
- Dividend Yield
- ASRT N/A
- ADAG N/A
- EPS Growth
- ASRT N/A
- ADAG N/A
- EPS
- ASRT N/A
- ADAG N/A
- Revenue
- ASRT $117,099,000.00
- ADAG $103,204.00
- Revenue This Year
- ASRT N/A
- ADAG $7,411.34
- Revenue Next Year
- ASRT $4.10
- ADAG $28.29
- P/E Ratio
- ASRT N/A
- ADAG N/A
- Revenue Growth
- ASRT N/A
- ADAG N/A
- 52 Week Low
- ASRT $0.51
- ADAG $1.30
- 52 Week High
- ASRT $1.08
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- ASRT 47.44
- ADAG 53.39
- Support Level
- ASRT $0.71
- ADAG $1.44
- Resistance Level
- ASRT $0.95
- ADAG $1.96
- Average True Range (ATR)
- ASRT 0.05
- ADAG 0.19
- MACD
- ASRT 0.01
- ADAG 0.02
- Stochastic Oscillator
- ASRT 35.83
- ADAG 71.12
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.